News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on HeraMED.
RELATED STOCKHEAD STORIES
News
Top 10 at 11: Which biotechs are up after positive study results and deals?
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: Immuron chalks up record half for travelers’ diarrhoea medicine, Travelan
News
Market Highlights: Europe stocks tumble on ECB comments, Davos kicks off, and 5 small caps to watch
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX down but smiles all round after surprise M&A Monday
News
In Case You Missed It: Takeovers, healthcare deals and some lithium
News
ASX Small Caps Lunch Wrap: Who’s ready to get violently ill on cheese-flavoured booze this Xmas?
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: Painchek’s Europe patent accepted; and HeraMed signs deal with Telstra Health
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX up for another day, Optus plugs back in as Telstra gains
News
In Case You Missed It: HeraMed soars 36pc on maternity platform trial
Health & Biotech
ASX Health Stocks: HeraMED jumps 30pc after maternity care platform goes live at clinical trial
News
10 at 11ish: Identified pegmatites spur Golden State Mining to kick off drilling at Paynes Find
News
Market Highlights: Iron ore, oil and gold stocks on watch today after prices slump on weak China data
News
